Ohfuji, Satoko
Kondo, Kyoko
Ito, Kazuya
Kase, Tetsuo
Maeda, Akiko
Fukushima, Wakaba
Masuda, Taisei
Kano, Munehide http://orcid.org/0000-0002-0541-3539
Funding for this research was provided by:
Takeda Pharmaceutical Co., Ltd.
Article History
Received: 29 August 2018
Accepted: 22 April 2019
First Online: 9 May 2019
Ethics approval and consent to participate
: The study protocol was approved by the ethics committees of Osaka City University Graduate School of Medicine (No. 3140) and Takeda Pharmaceutical Company Limited (EPI-011). Informed consent of each patient was waived by the ethics committees (No. 3140 and EPI-011), because this study used anonymized data which was retrospectively collected from medical records at the responded medical institutes.
: Not applicable.
: SO received a research grant from Takeda Pharmaceutical Company Limited. TM and MK are employees of Takeda Pharmaceutical Company Limited. Other authors declare no conflicts of interest.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.